Ranbaxy Laboratories Ltd., an India-based pharmaceutical company, has requested a class certification hearing related to their cholesterol medication, Lipitor, to be postponed. The request submitted to a New Jersey federal court cites a unique predicament – one of their attorneys, who has yet to be identified, is said to be trapped in a war zone in Israel, with no immediate plan for extraction.
These details emerged as part of ongoing multidistrict antitrust litigation revolving around Lipitor, a widely-used cholesterol medication. Extensive details about the case or its current status within the court system were not readily available at the time of reporting.
For legal professionals and interested parties, keeping abreast of these developments could prove crucial – understanding how courts react to such extraordinary circumstances might set precedents for future exigencies. For more information, please refer to the initial summary on Law360.